
Stigma surrounding Alzheimer’s disease may discourage Americans from learning about their risk and from joining clinical trials for potential new treatments, a small survey reveals. “We found that concerns about discrimination and overly harsh judgments about the severity of symptoms were most prevalent,” lead researcher Shana Stites said in an Alzheimer’s Association news release. “By… read on >